CX3CR1-KD or/and LFA-1-KD treatments also downregulated the aggressive propensity of tumor cells, as evidenced by reduced levels of phosphorylated PI3K and AKT, and decreased levels of MMP-2, compared with controls (Figure S5F). The gene discussed is MMP2; the disease is neoplasm.